SHANTOU , December 10 , SinoCast — Guangdong Taiantang Pharmaceutical Co., Ltd. (SZSE: 002433) revealed plans to finance CNY 1.604 billion from a private placement for not lower than CNY 16.04 per share. Financing will be put into five projects including building an industrial park for traditional Chinese medicinal materials in Bozhou City, Anhui Province , central China . Guangdong Taiantang believed that increasing aging population will boost consumption of drugs and healthcare products, in turn stimulating demand for traditional Chinese medicinal materials, Chinese herbal pieces and Chinese patent drugs, which will create new growth poles.
Comments are closed.